Benzinga's Top Pre-Market Losers
Cytokinetics (NASDAQ: CYTK) shares dropped 19.68% to $8.41 in pre-market trading on failed Phase 2 ATOMIC-AHF study.
Murphy Oil (NYSE: MUR) dipped 5.10% to $63.98 in the pre-market session. Murphy Oil completed the spin-off of Murphy USA Inc.
Microsoft (NASDAQ: MSFT) shares fell 4.73% to $31.82 in the pre-market trading after the company announced its plans to buy Nokia's (NYSE: NOK) cellphone business for 5.44 billion euros ($7.2 billion).
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.